Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation (2011)
- Authors:
- USP affiliated authors: FANELLI, CAMILLA - FM ; FUJIHARA, CLARICE KAZUE - FM ; ZATZ, ROBERTO - FM
- Unidade: FM
- DOI: 10.1152/ajprenal.00042.2011
- Subjects: NEFROPATIAS (TERAPIA); ANGIOTENSINA II; INSUFICIÊNCIA RENAL CRÔNICA (TERAPIA;CONTROLE)
- Language: Inglês
- Imprenta:
- Source:
- Título: American Journal of Physiology. Renal Physiology
- ISSN: 1931-857X
- Volume/Número/Paginação/Ano: v. 301, n. 3, p. F580-F587, 2011
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FANELLI, C. et al. Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation. American Journal of Physiology. Renal Physiology, v. 301, n. 3, p. F580-F587, 2011Tradução . . Disponível em: https://doi.org/10.1152/ajprenal.00042.2011. Acesso em: 13 fev. 2026. -
APA
Fanelli, C., Fernandes, B. H. V., Machado, F. G., Okabe, C., Malheiros, D. M. A. C., Fujihara, C. K., & Zatz, R. (2011). Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation. American Journal of Physiology. Renal Physiology, 301( 3), F580-F587. doi:10.1152/ajprenal.00042.2011 -
NLM
Fanelli C, Fernandes BHV, Machado FG, Okabe C, Malheiros DMAC, Fujihara CK, Zatz R. Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation [Internet]. American Journal of Physiology. Renal Physiology. 2011 ; 301( 3): F580-F587.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1152/ajprenal.00042.2011 -
Vancouver
Fanelli C, Fernandes BHV, Machado FG, Okabe C, Malheiros DMAC, Fujihara CK, Zatz R. Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation [Internet]. American Journal of Physiology. Renal Physiology. 2011 ; 301( 3): F580-F587.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1152/ajprenal.00042.2011 - Associação terapêutica de losartan (L) e hidroclorotiazida (H) previne progressão da lesão renal em modelo de nefropatia crônica resultante da administração de (L) durante a lactação
- Furosemide (F) is less effective than hydroclorothiazide (H) as adjuvant to losartan (L) in arresting the nephropathy associated with the 5/6 renal ablation model (NX)
- Losartan (L) and hydrochlorotiazide (H) association (LH) arrests renal inhury in a model of very advanced chronic kidney disease (CKD)
- Losartan (L) and Hydrochlorothiazide (H)Treatment (LH) arrests renal and cardiac injury in advanced chronic kidney disease by mechanisms not entireky dependent on blood pressure
- Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload
- Mechanisms of progressive renal injury in adult rats treated with losartan during lactation
- NF-κB activation mediates crystal translocation and interstitial inflammation in adenine overload nephropathy
- High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac)
- Regression of diabetic nephropathy: no dose-response effect of an angiotensin II antagonist
- An association of losartan-hydrochlorothiazide, but not losartan-furosemide, completely arrests progressive injury in the remnant kidney
Informações sobre o DOI: 10.1152/ajprenal.00042.2011 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
